Literature DB >> 11859033

Yellow fever vaccine.

Philip P Mortimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11859033      PMCID： PMC1122380          DOI： 10.1136/bmj.324.7335.439

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787-800 (1937)

Authors:  M Theiler; H H Smith
Journal:  Rev Med Virol       Date:  2000 Jan-Feb       Impact factor: 6.989

2.  Effects of yellow fever vaccination.

Authors:  N Troillet; F Laurencet
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

3.  Effects of yellow fever vaccination.

Authors:  V Adhiyaman; A Oke; C Cefai; V Adhiyaman; A Oke; C Cefai
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

4.  Effects of yellow fever vaccination.

Authors:  U Werfel; W Popp
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

5.  Hepatitis and death following vaccination with 17D-204 yellow fever vaccine.

Authors:  R C Chan; D J Penney; D Little; I W Carter; J A Roberts; W D Rawlinson
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

6.  Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases.

Authors:  P F Vasconcelos; E J Luna; R Galler; L J Silva; T L Coimbra; V L Barros; T P Monath; S G Rodigues; C Laval; Z G Costa; M F Vilela; C L Santos; P M Papaiordanou; V A Alves; L D Andrade; H K Sato; E S Rosa; G B Froguas; E Lacava; L M Almeida; A C Cruz; I M Rocco; R T Santos; O F Oliva; C M Papaiordanou
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

7.  Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

Authors:  M Martin; T F Tsai; B Cropp; G J Chang; D A Holmes; J Tseng; W Shieh; S R Zaki; I Al-Sanouri; A F Cutrona; G Ray; L H Weld; M S Cetron
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

8.  Advanced age a risk factor for illness temporally associated with yellow fever vaccination.

Authors:  M Martin; L H Weld; T F Tsai; G T Mootrey; R T Chen; M Niu; M S Cetron
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

9.  A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army.

Authors:  L B Seeff; G W Beebe; J H Hoofnagle; J E Norman; Z Buskell-Bales; J G Waggoner; N Kaplowitz; R S Koff; J L Petrini; E R Schiff
Journal:  N Engl J Med       Date:  1987-04-16       Impact factor: 91.245
  9 in total
  2 in total

Review 1.  Recent developments: Travel medicine.

Authors:  Jane N Zuckerman
Journal:  BMJ       Date:  2002-08-03

2.  Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections.

Authors:  Christina A Scherer; Charles L Magness; Kathryn V Steiger; Nicholas D Poitinger; Christine M Caputo; Douglas G Miner; Patricia L Winokur; Donna Klinzman; Janice McKee; Christine Pilar; Patricia A Ward; Martha H Gillham; N Jean Haulman; Jack T Stapleton; Shawn P Iadonato
Journal:  Vaccine       Date:  2007-07-06       Impact factor: 3.641
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.